Idiopathic Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Idiopathic Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Phase 1, Open-Label Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy Participants [Phase 1]
Phase 1 open-label study to evaluate pharmacokinetics and potential drug-drug interactions of ENV-101 (taladegib) in healthy participants. I…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
An update on a Phase 2 clinical trial evaluating oral Ifetroban for idiopathic pulmonary fibrosis (IPF), which is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Phase Ia Clinical Trial of HW241045 [Phase 1]
A Phase 1 trial of HW241045 in healthy volunteers and idiopathic pulmonary fibrosis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: The relatıonshıp Between Upper Extremity Exercise Test and Exercise Capacity ın patıents wıth Idiopathic Pulmonary Fibrosis
This clinical trial update reports on the relationship between upper-extremity exercise tests and exercise capacity in patients with idiopat…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL) [Phase 2]
A Phase 2 extension study for subjects who received Avalyn's inhaled antifibrotic agent (SAIL) is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]
Phase II clinical trial of BC006 for idiopathic pulmonary fibrosis is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: Application of Personalized Palliative Care in Patients With Newly Diagnosed Idiopathic Pulmonary Fibrosis
A completed clinical trial examining the use of personalized palliative care for patients newly diagnosed with idiopathic pulmonary fibrosis…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis [Phase 3]
Phase 3 clinical trial evaluating glucocorticoids versus placebo for acute exacerbation of idiopathic pulmonary fibrosis is currently recrui…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: H01 in Adults With Interstitial Lung Disease (The SOLIS Study) [Phase 2]
The SOLIS study is a Phase 2 clinical trial sponsored by NIEHS evaluating H01 in adults with interstitial lung disease, including idiopathic…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients [Phase 1]
A Phase 1 clinical trial update describes preliminary evaluation of the radiotracer [68Ga]CBP8 in healthy individuals, lung cancer patients,…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Autoantibody Reduction for Acute Exacerbations of Idiopathic Pulmonary Fibrosis [Phase 2]
A Phase 2 trial evaluating autoantibody reduction in acute exacerbations of idiopathic pulmonary fibrosis has completed with results posted.
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Xenon MRI and Progressive ILD [Phase 2]
A Phase 2 Duke University trial is investigating Xenon MRI imaging for progressive interstitial lung diseases, including idiopathic pulmonar…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial) [Phase 2]
A Phase 2 clinical trial evaluating ENV-101 for idiopathic pulmonary fibrosis and progressive fibrosing interstitial lung disease is listed …
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Atezolizumab for Idiopathic Pulmonary Fibrosis [Phase 1]
A Phase 1 clinical trial evaluating atezolizumab for idiopathic pulmonary fibrosis is ongoing but not currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
A Phase 2 trial evaluating Boehringer Ingelheim's BI 1819479 for improving lung function in idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
A clinical trial update for a prospective outcomes registry involving idiopathic pulmonary fibrosis and other interstitial lung diseases, cu…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Anlotinib Capsules in the Treatment for IPF/PF-ILDs [Phase 2, Phase 3]
Clinical trial update on Anlotinib capsules for idiopathic pulmonary fibrosis and progressive fibrosing interstitial lung disease. The Phase…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SRN001 in Healthy Korean and Caucasian Adult Males [Phase 1]
Phase 1 clinical trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of SRN001 in healthy Korean and Caucasian …
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: OPEN-IPF: Observational Prediction modEl for cliNical Outcomes in Idiopathic Pulmonary Fibrosis
OPEN-IPF is an observational study aimed at predicting clinical outcomes in idiopathic pulmonary fibrosis. The trial is currently not recrui…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]
A Phase 2 clinical study is evaluating SV001 for safety, tolerability, pharmacokinetics and immunogenicity in people with idiopathic pulmona…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Management of Progressive Disease in Idiopathic Pulmonary Fibrosis [Phase 4]
A Phase 4 clinical trial investigating management of progressive disease in idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease [Phase 2]
Phase 2 study evaluating the efficacy and safety of vixarelimab in idiopathic pulmonary fibrosis and systemic sclerosis-associated interstit…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Inspiratory Effort Assessed Through Nasal Pressure Measurement in Patients With Idiopathic Pulmonary Fibrosis
A clinical trial evaluating inspiratory effort via nasal pressure measurement in patients with idiopathic pulmonary fibrosis is currently re…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis [Phase 2]
A Phase 2 clinical trial evaluating PIPE 791 for idiopathic pulmonary fibrosis is currently recruiting to assess its efficacy, safety, and t…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis [Phase 1]
This clinical trial update describes a Phase 1 study evaluating autologous lung stem cell transplantation for idiopathic pulmonary fibrosis …